URL: http://www.leukemia-net.org/content/e58/e525/e531/index_eng.html

ELN

Leukemias

MDS

Contact ·

Contact Persons in Project 8: Myelodysplastic syndromes (MDS)

Created by: Hellenbrecht (ELIC) , generated 2006/03/14, last changed: 2008/06/04

Name	Initials	Clinic	Country
Lead Participants
T. De Witte	DEW	University Medical Center St Radboud	Netherlands
Participants
J. Apperley *	APP	Imperial College London	UK
C. Aul	AUL	St. Johannes Hospital	Germany
G. Basso	BASS		Italy
P. Bernasconi	BERP	Universita degli Studi di Pavia	Italy
C. Bernasconi	BERN	Fondazione Collegio Ghislieri	Italy
B. Bowen	BOW	University of Dundee	UK
T. Büchner	BUE		Germany
A. Burnett	BUR		UK
M. Cazzola	CAZ	Universita degli Studi di Pavia	Italy
J. Cermak	CER	Institute of Hematology and Blood Transfusion	Czech Republic
M. Della Porta	DELL		Italy
P. Fenaux	FEN	Hopital Avicenne (CHU Paris 13)	France
A. Ganser	GAN	Medizinische Hochschule Hannover	Germany
N. Gattermann	GAT	Universitätsklinikum Düsseldorf	Germany
U. Germing	GERM	Universitätsklinikum Düsseldorf	Germany
A. Giagounidis	GIAG		Germany
R. Gologan	GOL		Romania
D. Heim	HEI		Switzerland
E. Hellström-Lindberg *	HELI	Karolinska Institutet	Sweden
W.K. Hofmann	HOF	Klinikum Benjamin-Franklin, Charité	Germany
S.E. Jacobsen	JACO	Lunds Universitet	Sweden
H. Jansen	JAN	Stichting Katholieke Universiteit, Univ. Medical Center	Netherlands
W. Kern	KERN		Germany
T. Khalid	KHA		UK
P. Klener	KLEN	Institute of Hematology and Blood Transfusion	Czech Republic
N. Kröger	KROE		Germany
K.-H. Lee	LEE		Germany
M. Lübbert	LUEB	Universitätsklinikum Freiburg	Germany
L. Malcovati	MALC		Italy
R. Marrtino	MARR		Spain
M. Mittelman	MIT		Israel
B. Mohr *	MOH		Germany
G. Mufti	MUFT	King´s College	UK
P. Muus *	MUU		Netherlands
U. Oelschlägel *	OEL		Germany
A. Orfao	ORF		Spain
G.J. Ossenkoppele	OSS	VU Academic Medical Center	Netherlands
R.A. Padua *	PAD	King´s College	UK
S. Peters	PETE		Germany
A. Porwitt-MacDonald *	POR		Sweden
C. Preudhomme	PRE	Centre Hospitalier-Regional, Universitaire de Lille	France
Rockemer-Vogt	ROCK		Germany
E. Roman	ROM		UK
M. Sanz	SAN		Spain
G. Sanz	SANZ	Fundación Hospital Universitario "La Fe"	Spain
A. Schmitt-Gräff	SCHG		Germany
H. Serve	SER	Universitätsklinikum Frankfurt	Germany
M. Stadler	STA		Germany
R. Stauder	STAU		Austria
G. Verhoef	VER	Katholieke Universiteit	Netherlands
* = Female Researcher

Lead Participants:

Prof.Dr. T. De Witte (Nijmegen, Netherlands): Prof. T. de Witte is Head of the department of Hematology, at the University Hospital of Nijmegen. He is chairman of the board of the Leukemia Group of the EORTC (2000-), treasurer of the Board European Group for Blood and Marrow Transplantation (1996-2002), Chairman of the EBMT MDS subcommittee, president of the Dutch Society for Hematology (1994-2000), and national councillor of the International Society of Haematology (1994- ). He is active as Co- Editor of Leukemia (1995-), Annals of Haematology (1999- ), and European Journal of Haematology (1998- ). Study co-ordinator of several international studies in MDS within EBMT (chairman of the MDS subcommittee) and EORTC study groups, including a Biomed-2 project on molecular studies in MDS (Criant).

Participants:

Prof.Dr. J. Apperley (London, UK):

Prof.Dr. C. Aul (Duisburg, Germany): He is member of the German Competence Network „acute and chronic leukemias“ and is currently Head of the department of hematology and oncology at St. Johannes Hospital in Duisburg. His primary fields of interest in hematology are myelodysplastic syndromes and leukemias.

G. Basso (, Italy):

Prof.Dr. P. Bernasconi (Pavia, Italy):

Prof.Dr. C. Bernasconi (Pavia, Italy): Chairman of the Italian Registry of Myelodysplastic Syndromes (RISMD). He coordinates with Dr Mario Cazzola the Pavia MDS research group. This research group focuses on mechanisms of apoptosis, diagnostic tools (multicolour flowcytometry, clonal analyses, methylation studies), translational molecular studies (iron metabolism, mitochondrial ferritin studies) and it participates in various clinical protocols.

Prof.Dr. B. Bowen (Dundee, UK): Head dept. Hematology, Ninewells Hospital, Dundee. He coordinates the regional MDS registry, including a tissue bank. He has created the first European registry from an unselected population. Chairman of the Dundee MDS research group which focusses on translational molecular studies.

Prof.Dr. T. Büchner (, Germany):

A. Burnett (, UK):

Prof.Dr. M. Cazzola (Pavia, Italy): Prof. of Hematology at the University of Pavia Medical School. Reseach contribution on erythroid marrow function in anemic patients, genetic disorder of iron metabolism and their molecular basis, and the pathogenesis of myelodysplastic syndromes. Editor in Chief of Haematologica/Journal of Hematology.

Dr. J. Cermak (Prague, Czech Republic):

M. Della Porta (, Italy):

Prof.Dr. P. Fenaux (Paris, France):

Prof.Dr. A. Ganser (Hannover, Germany):

PD Dr. N. Gattermann (Düsseldorf, Germany): University of Düsseldorf. Current research: Biological significance of mitochondrial DNA mutations in MDS.

PD Dr. U. Germing (Düsseldorf, Germany): Member of the German MDS-Study Group and the German MDS- Foundation. Longstanding experience in clinical research on MDS.

A. Giagounidis (, Germany):

R. Gologan (, Romania):

D. Heim (, Switzerland):

Dr. E. Hellström-Lindberg (Stockholm, Sweden): Staff member and head of the MDS Research group at the Hematology Laboratory, Huddinge University Hospital, Stockholm, Sweden. She is founder and president for the Nordic MDS Group (NMDSG). She has numerous international scientific board positions, including councillor of the Board for European Hematology Association, and board member MDS Foundation. She is member of the editorial board for Leukemia Research, Haematologica, and International Journal of Hematology.

Prof.Dr. W.K. Hofmann (Berlin, Germany):

Prof.Dr. S.E. Jacobsen (Lund, Sweden): Professor of Stem Cell Biology. Molecular regulation of hematopoiesis and hematopietic stem cell fate decisions.

Dr. H. Jansen (Nijmegen, Netherlands): Head of Dept of Molecular Hemato-Oncology and Molecular Diagnostics, Hematology UMCN Nijmegen. Coordinator of the molecular studies for the EORTC AML and MDS trials (AML-12, AML-17 and MDS-CRIANT studies). Head of reference laboratory. Chairman for the Dutch-Belgian-Swiss Network for molecular diagnostics in hemato-oncology in which all Dutch and various Belgian and Swiss centers participate.

W. Kern (, Germany):

T. Khalid (, UK):

P. Klener (Prague, Czech Republic):

N. Kröger (, Germany):

K.-H. Lee (, Germany):

Prof.Dr. M. Lübbert (Freiburg, Germany): Molecular mechanisms of normal myeloid differentiation and differentiation in acute myeloid leukemias, the characterisation of human hematopoietic stem cells, clinical studies on therapy with demethylating substances in myelodysplastic syndromes and myeloid leukemias.

L. Malcovati (, Italy):

R. Marrtino (, Spain):

M. Mittelman (, Israel):

B. Mohr (, Germany):

Prof.Dr. G. Mufti (London, UK): Professor of Hemato-Oncology, Guy’s, King’s & St. Thomas’s (GKT) School of Medicine, Honorary Consultant King’s College Hospital NHS Trust, Director of Clinical Laboratory Sciences, King’s College Hospital NHS Trust, Head, Department of Hematological Medicine, Head of Division of Clinical Laboratory Sciences, GKT School of Medicine (1999 - 2002). Co-ordinator of the MRC MDS trials. Co-ordinator of the EORTC trial on intensive chemotherapy and peripheral blood stem cell transplant in myelodysplastic syndrome. Member and founder member of the MDS International Symposia and MDS Foundation. Organiser of several International Congresses.

P. Muus (, Netherlands):

U. Oelschlägel (, Germany):

A. Orfao (, Spain):

Prof.Dr. G.J. Ossenkoppele (Amsterdam, Netherlands):

Dr. R.A. Padua (London, UK): King’s College Hospital. Major research interest is the study of myelodysplasia (MDS). She is currently using a genetic approach to create animal models of MDS using transgenic mice harbouring the genes thought to be involved in MDS, with the view of using these models to test targeted therapeutic strategies. Presently head of the Minimal Residual Disease for Adult Leukemia Section at King’s College Hospital. Clinical trials involving MDS, reduced conditioning strategies.

S. Peters (, Germany):

A. Porwitt-MacDonald (, Sweden):

Dr. C. Preudhomme (Lille, France): Dept. of Hematology, Calmette Hospital CHU, Lille. Identification of genetic alterations in AML cases lacking chromosomal translocations, identifying point mutations in genes encoding transcription factors or receptor tyrosine kinases. Current research interests include identification of novel molecular markers in AML and comparison of molecular and immunological based methods for MRD detection. They are actively involved in establishing collaborative studies with other leukemia diagnostic laboratories in France, thereby providing a mechanism for spread of excellence beyond our Network.

Rockemer-Vogt (, Germany):

E. Roman (, UK):

M. Sanz (, Spain):

Dr. G. Sanz (Valencia, Spain): Clinical Hematology, Leukemia and Bone Marrow Transplant Unit, Hospital La Fe, Valencia. Clinical research in clinical hematology, special interest in leukemias, MDS and allogeneic stem cell transplantation. Member of the Editorial Board of Haematologica and Leukemia Research. As active member of the Spanish and International MDS Study Groups, he contributed to the development of the Spanish and International Prognostic Scoring Systems for MDS. Responsible for undertaking and co-ordinating clinical studies for MDS patients in the Spanish PETHEMA cooperative group for patients with MDS.

A. Schmitt-Gräff (, Germany):

Prof.Dr. H. Serve (Frankfurt, Germany):

M. Stadler (, Germany):

R. Stauder (, Austria):

Prof.Dr. G. Verhoef (Leuven, Netherlands):